ESBATech initiates Phase Ib/IIa cataract surgery trial
This study is designed to evaluate the safety, tolerability, and ocular pharmacokinetics of topically applied ESBA105 in patients, as well as assess the preventive activity on ocular inflammation
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.